SAN DIEGO--(BUSINESS WIRE)--Aries Pharmaceuticals, Inc. (Aries) today announced the launch and commercial availability of its first product, Eleview™, a novel, ready to use, submucosal injectable ...
SAN DIEGO--(BUSINESS WIRE)--Aries Pharmaceuticals, Inc. (Aries), a specialty pharmaceutical company commercializing best-in-class gastroenterology products utilized in endoscopy and for the treatment ...
Aries Pharmaceuticals launched its submucosal injectable composition Eleview. Here's what you should know. 1. Eleview allows providers to remove polyps, adenomas, early stage cancers and other lesions ...
Dublin, Ireland - 3 May 2022: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) ('Cosmo') announces the expansion of the agreement with Medtronic for the distribution of Eleview(R) to all countries ...
Dublin, December 2, 2019 - Cosmo Pharmaceuticals NV (SIX: COPN) announced today that it has entered into a new worldwide supply and distribution agreement for Eleview with Medtronic (with the ...
Here’s what you should know. 1. Eleview allows providers to remove polyps, adenomas, early stage cancers and other lesions in the gastrointestinal tract. 2. Cosmo Pharmaceuticals developed Eleview.
Cosmo Pharmaceuticals N.V. / Key word(s): Miscellaneous COSMO ANNOUNCES EXPANDING THE AGREEMENT WITH MEDTRONIC FOR ELEVIEW(R) TO ALL COUNTRIES EXCEPT CANADA 03.05.2022 / 06:00 Dublin, Ireland - 3 May ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results